CPX-351: an attractive option for the treatment of older patients with high-risk or secondary acute myeloid leukaemia

Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Xavier Thomas, Adriana Plesa
Source: The Lancet Haematology - Category: Hematology Source Type: research